A clinical trial registered on ClinicalTrials.gov will evaluate whether the AI-HEALS artificial intelligence mobile health intervention, based on symptom management theory, can improve quality of life among adult female patients receiving adjuvant therapy after surgery for stage I–III breast cancer. The study will compare an intervention group with a standard care group. The intervention group will use WeChat for six months to record symptoms, receive personalized health content, and participate in online follow-up. Outcomes will include anxiety, depression, self-efficacy, self-management abilities, and eHealth literacy.
Source:ClinicalTrials.gov 肿瘤新登记试验 · Read Original
Leave a Reply